Cancer news from the American Cancer Society.
Published on: June 1, 2023
Follow research highlighted each day in this ongoing meeting by checking out the ASCO News Highlights for People with Cancer blog.
Published on: June 18, 2020
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug pembrolizumab (Keytruda) to include any cancer with a high tumor mutational burden (TMB-H).
Published on: March 19, 2020
Medicare has changed its policies to make it easier for older Americans to “see” their doctors without going in for an office visit, using their home computer or other device.
Published on: January 10, 2020
The US Food and Drug Administration (FDA) has approved Ayvakit (avapritinib) to treat people with advanced cases of gastrointestinal stromal tumor (GIST) that have a certain genetic mutation.
Published on: December 20, 2019
The US Food and Drug Administration (FDA) has approved a new type of drug for certain people with bladder cancer.